We have shown that exogenous administration of gastrin-17 (G17) peptide could promote AGS gastric cancer cells proliferation and upregulate RegIα expression [14], but whether the gastrin is associated with the expression of RegIα  in vivo remains unclear. This evidence concerns the gene GAST and gastric cancer.